A new murine Helicobacter species, Helicobacter hepaticus, infects the livers of mice, causing a progressive chronic active hepatitis culminating in hepatocellular tumors. To examine the role of chronic H. hepaticus infection in carcinogenesis, H. hepaticus-infected male infant mice of A/JCr strain were given a single ip dose of N-nitrosodimethylamine (NDMA). Noninfected A/J mice similarly treated with NDMA served as controls. The effect of hepatitis induced by H. hepaticus was studied for 64 wk. At 31-36 wk, the incidence of hepatocellular adenomas in infected mice was significantly higher than in noninfected mice (82 vs 52%; p = 0.05). The multiplicity of hepatocellular tumors was also significantly higher in infected mice compared to noninfected mice (3.2 ± 0.09 vs 0.09 ± 0.2; p = 0.03). At 51-64 wk, many (10/18) infected mice developed hepatocellular carcinomas while only 2 of 19 control mice developed such tumors (p = 0.005). Overexpression of cyclin D was observed in hepatocytes as well as adenomas induced by NDMA in H. hepaticus-infected mice, suggesting its role in inflammation, abnormal cell growth, and early neoplasia. High molecular weight keratins were highly expressed in hyperplastic oval cells in hepatitis and in liver tumors in mice with hepatitis, establishing a reliable marker for oval cells in formalin-fixed, paraffin-embedded tissue. Thus, chronic H. hepaticus infection significantly stimulated cyclin D expression, accelerated the development of liver tumors, increased the multiplicity of such lesions, and enhanced the progression of benign to malignant tumors.
Anderson LM, Ward JM, Fox SD, Issaq HJ, and Riggs CW (1986). Effects of a single dose of polychlorinated biphenyls to infant mice on N-nitrosodimethylamine-initiated lung and liver tumors. Int. J. Cancer38: 109-116.
2.
Bartcova J., Lukas J., Strauss M., and Bartek J. (1995). Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene10: 775-778.
3.
Canella KA, Diwan BA, Gorelick PL, Donovan PJ, Sipowicz MA, Kasprzak KS, Weghorst CM, Snyderwine EG, Davis CD, Keefer LK, Kyrtopoulos SA, Hecht SS, Wang M., Anderson LM, and Rice JM (1996). Liver tumorigenesis by Helicobacter hepaticus: Consideration of mechanism. In Vivo10: 285-292.
4.
Diwan BA, Rice JM, Ohshima M., and Ward JM (1986). Interstrain differences in susceptibility to liver carcinogenesis initiated by N-nitrosodiethylamine and its promotion by phenobarbital in C57BL/ 6NCr, C3H/HeNCrMTV- and DBA/2NCr mice. Carcinogenesis7: 215-220.
5.
Diwan BA, Rice JM, and Ward JM (1990). Strain-dependent effects of phenobarbital on liver tumor promotion in inbred mice. In: Mouse Liver Carcinogenesis: Mechanisms and Species Comparisons, Vol. 331, DE Stevenson, RM McClain, JA Popp, TJ Slaga , JM Ward, and HC Pitot (eds). Wiley-Liss, New York, pp. 69-83.
6.
Filmus J., Robles AL, Shi W., Wong MJ, Colombo LL, and Conti CI (1994). Induction of cyclin D1 overexpression by activated ras. Oncogene9: 3627-3633.
7.
Flaks A. (1968) The susceptibility of various strains of neonatal mice to the carcinogenic effects of 7,12-dimethyl-1,2-benzanthracene. Eur. J. Cancer4: 579-585.
8.
Flavell DJ and Lucas SB (1983). Promotion of N-nitrosodimethylamine-initiated bile duct carcinogenesis in the hamster by the human liver fluke, Opisthorchis viverrini. Carcinogenesis4: 927-930.
9.
Fox JG, Dewhirst FE, Tulley JG, Paster BJ, Yan L., Taylor NS, Collins MJ, Gorelick PL, and Ward JM (1994). Helicobacter hepaticus, sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice . J. Clin. Microbiol. 32: 1238-1245.
10.
Fox JG, Li X., Yan R., Cahill RJ, Hurley R., Lewis R., and Murphy JC (1996). Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: A model of Helicobacter-induced carcinogenesis. Infect. Immun. 64: 1548-1558.
11.
Fox JG, Wishnok JS, Murphy JC, Tannenbaum SR, and Correa P. (1993). MNNG-induced gastric carcinoma in ferrets infected with Helicobacter mustelae. Carcinogenesis14: 1957-1961.
12.
Fox JG, Yan L., Shames B., Campbell, J., Murphy JC, and Li X. (1996) Persistent hepatitis and enterocolitis in germfree mice infected with Helicobacter hepaticus. Infect. Immun. 64: 3673-3681.
13.
Frith CH and Ward JM (1979). A morphologic classification of proliferative and neoplastic hepatic lesions in mice. J. Environ. Path. Toxicol. Oncol. 3: 329-351.
14.
Fukushima S. and Cohen SM (1980). Saccharin-induced hyperplasia of the rat urinary bladder. Cancer Res. 40: 734-736.
15.
Jiang W., Kahn SM, Zhou P., Zhang Y., Cacase AM, Infante AS, Doi S., Santella RM, and Weinstein IB (1993). Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression . Oncogene8: 3447-3457.
16.
Jiang W., Zhang YJ, Kahn SM, Hollstein MC, Santella RM, Lu S-H., Harris CC, Montesano R., and Weinstein IB (1993). Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc. Natl. Acad. Sci. USA90: 9026-9030.
17.
Lammie GA, Fantl JC, Smith R., Schuuring E., Brookes S., Michalides R., Dickson C., Arnold A., and Peters G. (1991). D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to Bcl-1. Oncogene6: 439-444.
18.
Lee G.-H, Nomura K., and Kitagava T. (1989). Comparative study of diethylnitrosamine-initiated two-stage hepatocarcinogenesis in C3H, C57BL and BALB mice promoted by various hepatopromoters. Carcinogenesis10: 2227-2230.
19.
Lijinsky W. ( 1983). Species specificity in nitrosamine carcinogenesis . In: Organ and Species Specificity in Chemical Carcinogenesis, Vol. 24, R Langenbach , S Nesnow, and JM Rice (eds). Plenum Press, New York , pp. 63-74.
20.
Matsuyama M. and Suzuki H. (1968). Strain differences in carcinogenesis by urethane administration to suckling mice with special reference to the induction of lung cancer. Br. J. Cancer22: 527-532.
21.
Raick AN, Thumm K., and Chivers BR (1972). Early effects of 12-O-tetradecanoylphorbol-13 acetate on the incorporation of tritiated precursor into DNA, and the thickness of interfollicular epidermis and their relation to tumor promotion in mouse skin. Cancer Res. 32: 1562-1568.
22.
Robles A. and Conti J. (1995). Early overexpression of cyclin D protein in mouse skin carcinogenesis. Oncogene8: 1127-1133.
23.
Ruggeri B., Caamano J., Goodrow T., DiRado M., Bianchi A., Trono D., Conti CJ, and Klein-Szanto AJP (1991). Alterations of the p53 tumor suppressor gene during mouse skin tumor progression. Cancer Res. 51: 6615-6621.
24.
Schilderman PA, ten Vaarwerk FJ, Lutgerink JT, Van der Wurff A., ten Hoor F., and Kleinjans JC (1995). Induction of oxidative DNA damage and early lesions in the rat gastrointestinal epithelium in relation to prostaglandin H synthase-mediated metabolism of butylated hydroxyanisole . Food Chem. Toxicol. 33: 99-101.
25.
Schreiber H. , Nettesheim P., Lijinsky W., Richter CB, and Walburg HE (1972). Induction of lung cancer in germfree, specific-pathogen-free, and infected rats by N-methyl-N'-nitro-N-nitrosoguanidine: Enhancement by respiratory infection . J. Natl. Cancer Inst . 49: 1107-1114.
26.
Searle CE and Jones EL (1976). The multipotential carcinogenic action of N-ethyl-N-nitrosourea administered neonatally to mice. Br. J. Cancer33: 612-635.
27.
Sgambato A. , Han EK, Zhang Y.-J, Moon RC, Santella RM, and Weinstein IB (1995). Deregulated expression of cyclin D and other cell cycle-related genes in carcinogen-induced rat mammary tumors. Carcinogenesis16: 2193-2198.
28.
Shubik P. (1984). Progression and promotion. J. Natl Cancer Inst. 73: 1005-1011.
29.
Sipowicz MA , Chomarat P., Diwan BA, Anver MA, Awasthi YC, Ward JM, Rice JM, Kasprzak KS, Wild PC, and Anderson LM (1997). Increased oxidative DNA damage and hepatocyte overexpression of specific cytochrome p450 isoforms in livers of mice infected with Helicobacter hepaticus . Am. J. Pathol. (in press).
30.
Sipowicz MA , Weghorst CM, Shio Y.-H, Buzard GS, Calvert RJ, Anver MR, Anderson LM, and Rice JM (1997). Lack of p53 and ras mutations in Helicobacter hepaticus-induced liver tumors in A/JCr mice. Carcinogenesis18: 233-236.
31.
Slaga TJ (1983). Overview of tumor promotion in animals. Environ. Health Perspect. 50: 3-14.
32.
Stenback F. , Mori H., Furuya K., and Williams GM (1986). Pathogenesis of dimethylnitrosamine-induced hepatocellular cancer in hamster liver and lack of enhancement by phenobarbital . J. Natl. Cancer Inst. 71: 815-823.
33.
Sumi Y. and Miyakava M. (1981). Comparative studies on the production of stomach tumors following the intubation of several doses of N-methyl-N'-nitro-N-nitrosoguanidine. Jpn. J. Cancer Res. 72: 700-704.
34.
Takayama S. and Oota K. (1965). Induction of malignant tumors in various strains of mice by oral administration of N-nitrosodimethylamine and N-nitrosodiethylamine. Jpn. J. Cancer Res. 56: 189-199.
35.
Timmins GS and Davies MJ (1993). Free radical formation in murine skin treated with tumor promoting organic peroxides. Carcinogenesis14: 1499-1503.
36.
Uchida E. and Hirono I. (1979). Effect of phenobarbital on induction of liver and lung tumors by dimethylnitrosamine in newborn mice. Jpn. J. Cancer Res. 70: 639-644.
37.
Ward JM, Anver MR, Haines DC, and Benveniste RE (1994). Chronic active hepatitis in mice caused by Helicobacter hepaticus. Am. J. Pathol. 145: 959-968.
38.
Ward JM, Fox JG, Anver MR, et al (1994). Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J. Natl. Cancer Inst. 86: 1222-1227.
39.
Weghorst CM , Pereira MA, and Klaunig JE (1989). Strain differences in hepatic tumor promotion by phenobarbital in diethylnitrosamine- and dimethylnitrosamine-initiated infant male mice. Carcinogenesis10: 1409-1412.
40.
Zhang S.-Y, Liu S.-C, Goodrow T., Morris R., and Klein-Szanto AJP (1997). Increased expression of G1 cyclins and cyclin-dependent kinases during tumor progression of chemically induced mouse skin neoplasms. Mol. Carcinog. 18: 142-152.
